Tissue atenolol levels following chronic β-adrenoceptor blockade using oral atenolol in dogs
- 1 April 1986
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 38 (4) , 316-319
- https://doi.org/10.1111/j.2042-7158.1986.tb04577.x
Abstract
Tissue atenolol concentrations are high following chronic continuous β-adrenoceptor blockade in dogs. Furthermore, significant concentrations of this poorly lipid soluble drug are found within the central nervous system after chronic dosing. It is suggested that all β-adrenoceptor blocking agents may enter the central nervous system in significant and sufficient quantities to account for a central antihypertensive action of this group of compounds. Sequestration of β-adrenoceptor agents in the CNS or other tissues may account for other clinically observed effects including adaptive effects.This publication has 15 references indexed in Scilit:
- The effects of Acute and Chronic β-Adrenoceptor Blockade on the Myofibrillar Contractile System in the Dog HeartClinical Science, 1984
- Pharmacokinetic studies with atenolol in the dogBiopharmaceutics & Drug Disposition, 1983
- Beta‐adrenoceptor blockers and the blood‐brian barrier.British Journal of Clinical Pharmacology, 1981
- β-Adrenoreceptor-Blocking Agents and the Blood-Brain BarrierClinical Science, 1980
- Effects of long term β-adrenoceptor blockadeJournal of Molecular and Cellular Cardiology, 1977
- Relationship between blood level of atenolol and pharmacologic effectClinical Pharmacology & Therapeutics, 1977
- Long term β-adrenergic blockade reduces tyrosine hydroxylase and dopamine β-hydroxylase activities in sympathetic gangliaNature, 1977
- Effects remaining after withdrawal of long-term beta-receptor blockade. Reduced heart rate and altered haemodynamic response to acute propranolol administration.Heart, 1976
- British Cardiac SocietyHeart, 1976
- Treatment of Hypertension with PropranololBMJ, 1969